▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

2seventy Bio (NASDAQ: TSVT)

Some price data may be temporarily unavailable.

2seventy Bio Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
TSVT	+14.16%			-64%
S&P	+16.07%	+97.84%	+14.62%	+44%

2seventy Bio Company Info

2seventy Bio, Inc. operates as cell and gene therapy company. It is focused on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

News & Analysis

Featured Article

2seventy Bio's Losses Narrow, Sales Dip

2seventy Bio notably reduced operating expenses in the third quarter, but revenue challenges persisted.

Motley Fool Markets Team | Nov 12, 2024

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services